Description
PRIVIGEN
First action · last action
2017-01-30 · 2018-03-08
Transactions
3
First transaction's obligation
$999,905
Base + all options value (sum of deltas)
$942,738
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797D50358
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2017-01-30+$999,905= $999,905
- Mod P000012017-03-21+$14,599= $1,014,504
- Mod P000022018-03-08-$71,766= $942,738
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2017-01-30 | +$999,905 | $999,905 | PRIVIGEN |
| Mod P00001· FUNDING ONLY ACTION | 2017-03-21 | +$14,599 | $1,014,504 | PRIVIGEN |
| Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2018-03-08 | −$71,766 | $942,738 | PRIVIGEN |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI H3WKVE9VBLY3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24826F0207 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $183,903 | FY2026 |
| 36C24826F0187 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $36,781 | FY2026 |
| 36C25226F0318 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $85,484 | FY2026 |
| 36C24826F0091 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $147,122 | FY2026 |
| 36C24826F0037 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $124,240 | FY2026 |
| 36C24824F0327 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $391,583 | FY2024 |
Other recipients under 6505 from 656-ST CLOUD VA MEDICAL CTR (00656) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C26318F0224 | HERITAGE HEALTH SOLUTIONS, INC. | 656-ST CLOUD VA MEDICAL CTR (00656) | $3,498 | FY2018 |
| 36C26318N0004 | BAXALTA US INC. | 656-ST CLOUD VA MEDICAL CTR (00656) | $52,329 | FY2018 |
| VA26317J1668 | AMERICAN NATIONAL RED CROSS, THE | 656-ST CLOUD VA MEDICAL CTR (00656) | $65,601 | FY2018 |
| VA26317J1625 | AMERICAN NATIONAL RED CROSS, THE | 656-ST CLOUD VA MEDICAL CTR (00656) | $884,044 | FY2018 |
| VA26317P1492 | MCKESSON CORPORATION | 656-ST CLOUD VA MEDICAL CTR (00656) | $37,166 | FY2017 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA26317J0227_3600_V797D50358_3600 · retrieved 2026-09-26.